Oasis Diagnostics Announces Grant Award From Oasis Diagnostics For Parkinson’s Disease

Published: Jan 08, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

VANCOUVER, Wash.--(BUSINESS WIRE)--Oasis Diagnostics® Corporation [OASIS] is the recipient of a research award from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to validate OASIS’ development of a non-invasive, saliva-based, rapid test for Parkinson’s disease detection and diagnosis. OASIS will collaborate with Dr. Charles Adler’s group at the Mayo Clinic in Scottsdale, Arizona to study proprietary biomarkers in saliva that are the subject of an exclusive license held by OASIS from Danish researchers.

Help employers find you! Check out all the jobs and post your resume.

Back to news